PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical 21st January 2020
PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development 4th November 2019
PhoreMost named ‘Biotech Company of the Year’ at Cambridge Independent Science and Technology Awards 2019 31st October 2019